MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 12-15-2022
OncoSec Medical Incorporated Current Ratio 2011-2026 | ONCS
Annual Current Ratio OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.39 | 3.09 | 2.36 | 5.73 | 4.89 | 3.68 | 8.49 | 11.6 | 29 | 2.92 | 2.72 | 0.444 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29 | 0.444 | 6.35 |
Quarterly Current Ratio OncoSec Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.3 | 0.94 | 1.39 | 1.98 | 3.2 | 2.71 | 3.09 | 3.09 | 1.19 | 1.92 | 1.87 | 1.87 | 4.27 | 2.92 | 5.33 | 5.33 | 5.41 | 4.61 | 4.13 | 4.13 | 5.28 | 3.63 | 3.36 | 3.36 | 7.59 | 6.31 | 7.44 | 7.44 | 21.7 | 9.57 | 12.3 | 12.3 | 22.1 | 27 | 29.8 | 33.5 | 3.98 | 9.2 | 3.68 | 3.68 | 0.59 | 1.95 | 2.47 | 2.47 | - | 1.16 | 0.71 | 0.71 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 33.5 | 0.59 | 6.49 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K |  USA |
 |
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | USA |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.85 | 3.22 % | $ 9.26 B |  Australia |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
1.19 | $ 327.0 | -1.92 % | $ 42.8 B | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 4.71 | -0.42 % | $ 766 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Cabaletta Bio
CABA
|
3.11 | $ 3.52 | 3.38 % | $ 354 M | USA |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | France |
 |
Aligos Therapeutics
ALGS
|
2.53 | $ 8.24 | 11.12 % | $ 81.5 M | USA |
 |
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M |  Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M | Britain |
 |
Applied Therapeutics
APLT
|
0.762 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.0929 | - | -2.5 % | $ 5.88 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.94 | $ 21.94 | 1.2 % | $ 1.03 B | USA |
 |
CymaBay Therapeutics
CBAY
|
3.05 | - | - | $ 3.45 B | USA |
 |
BioNTech SE
BNTX
|
7.95 | $ 100.85 | 1.39 % | $ 27.2 B | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M |  Canada |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 3.13 | -3.52 % | $ 5.15 M | Israel |
 |
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | USA |
 |
ContraFect Corporation
CFRX
|
0.636 | - | -5.16 % | $ 5.39 M | USA |
 |
Galectin Therapeutics
GALT
|
0.134 | $ 2.34 | -8.79 % | $ 150 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.09 | $ 1.4 | -10.0 % | $ 360 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
0.827 | $ 4.22 | -0.59 % | $ 451 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 24.2 | -1.55 % | $ 3.08 B | USA |
 |
Grifols, S.A.
GRFS
|
1.67 | $ 8.59 | -1.1 % | $ 6.83 B |  Spain |
 |
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.53 | 2.68 % | $ 407 M | Britain |
 |
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
6.16 | - | -16.75 % | $ 25.8 M | USA |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
Clearside Biomedical
CLSD
|
0.681 | - | - | $ 25.3 M | USA |
 |
Celldex Therapeutics
CLDX
|
10.4 | $ 33.66 | -0.62 % | $ 2.24 B | USA |
 |
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | USA |